Affymetrix (AFFX) to Collaborate with Massachusetts General Hospital to Develop New Oncology Biomarker Tests
Go back to Affymetrix (AFFX) to Collaborate with Massachusetts General Hospital to Develop New Oncology Biomarker Tests| Affymetrix, Inc. (NASDAQ: AFFX) | Delayed: 14.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.01 | 52 Week High | $16.15 | |||
| Open | $10.77 | 52 Week Low | $8.28 | |||
| Day High | $14.01 | P/E | N/A | |||
| Day Low | $14.01 | EPS | $-0.23 | |||
| Volume | 2,228 | |||||

